<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8FD2AECC-0F32-4049-9C11-30778D38EEEF"><gtr:id>8FD2AECC-0F32-4049-9C11-30778D38EEEF</gtr:id><gtr:name>University of Luxembourg</gtr:name><gtr:address><gtr:line1>University of Luxembourg</gtr:line1><gtr:line2>162A avenue de la Faiencerie</gtr:line2><gtr:postCode>L-1511</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4C862B58-35BC-4A9F-A962-4FCC64A29BE1"><gtr:id>4C862B58-35BC-4A9F-A962-4FCC64A29BE1</gtr:id><gtr:name>MRC Dementias Platform UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8FD2AECC-0F32-4049-9C11-30778D38EEEF"><gtr:id>8FD2AECC-0F32-4049-9C11-30778D38EEEF</gtr:id><gtr:name>University of Luxembourg</gtr:name><gtr:address><gtr:line1>University of Luxembourg</gtr:line1><gtr:line2>162A avenue de la Faiencerie</gtr:line2><gtr:postCode>L-1511</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4C862B58-35BC-4A9F-A962-4FCC64A29BE1"><gtr:id>4C862B58-35BC-4A9F-A962-4FCC64A29BE1</gtr:id><gtr:name>MRC Dementias Platform UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9F8F75E8-87B5-4842-975A-FEF86EB86988"><gtr:id>9F8F75E8-87B5-4842-975A-FEF86EB86988</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Wade-Martins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_EX_MR%2FN50192X%2F1"><gtr:id>C77EFE82-CBDF-4985-AECC-E831E9EEBA69</gtr:id><gtr:title>UKDP: Integrated DEmentiA research environment (IDEA)</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MC_EX_MR/N50192X/1</gtr:grantReference><gtr:abstractText>he UK Dementias Platform (UKDP) is a radically new approach to dementias research. It brings together data from around 2,000,000 study participants from 22 cohorts to try and discover the causes of dementia and to find out ways of slowing it down. The platform has been funded to the level of &amp;pound;12M. In this proposal we want to improve UK infrastructure for dementia research so that the most can be made of the opportunity provided by UKDP. We wan to improve the infrastructure by buying important pieces of equipment that will put the UK at the forefront of dementia research worldwide and by establishing networks of scientists who will work together to make best use of the equipment. The three themes of the proposal are imaging, informatics and stem cells. For imaging we want to establish a network of PET/MR scanning facilities across the UK so that the molecular processes going on inside the brain that cause dementia can be studied. For informatics we want to be bring together bas many different types of data as possible and make it easy as possible for scientists to use them For stem cells we want to take cells form adults with and without dementia to find out how cells change as the dementias process begins and progresses. We believe these proposals will raise standards, reduce costs, and deliver innovative and coordinated research, making the UK an internationally unique place to study dementia.</gtr:abstractText><gtr:technicalSummary>Our objective is to achieve a step-change in UK dementia research capacity through establishing national networks of existing and emerging centres of excellence in imaging, informatics and cell-biology. The UK Dementias Platform (UKDP) is a radically new approach to dementias research, providing a highly efficient and cost-effective translational pipeline from discovery through to early phase trials. UKDP will create closer synergy between epidemiology and experimental medicine with the re-purposing of epidemiologic cohorts for trials readiness. The size and depth of phenotyping available to UKDP will deliver a step-change in the complexity and granularity of dementia related
hypothesis testing and accelerate compound development. Proposed here is an infrastructure of investment and collaboration. Underpinning UKDP is a critical mass of researchers and resources that will work together to encourage, facilitate, and develop a fully integrated dementia dedicated UK research environment. This will raise standards, reduce costs, and deliver innovative and coordinated research, to make
the UK an internationally unique research environment. Through its partnership with major academic centres and industry, UKDP is well positioned to achieve this goal.
Building on the recent MRC investment in UKDP, we propose here to renew and extend the UKDP integrative research environment with an advanced molecular imaging network strategically located to exploit UKDP cohorts. Also proposed is
an integrated informatics environment to facilitate the location of and access to both data and bio-samples. The third proposal is for a stem-cells network to promote the use of this important and emerging technology. Each of these elements
adds value to existing infrastructure investments and fills significant gaps in the UK research landscape.</gtr:technicalSummary><gtr:fund><gtr:end>2018-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>Abeta functional assays</gtr:description><gtr:id>0AE296D2-C308-404B-900D-8D8118AEAC1F</gtr:id><gtr:impact>Ongoing collaboration</gtr:impact><gtr:outcomeId>56f5c8c42f3029.64134096-1</gtr:outcomeId><gtr:partnerContribution>Collaborative development of assay</gtr:partnerContribution><gtr:piContribution>We have worked to develop improved in vitro analysis odf Abeta function</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Electrophysiology in iPSC neurons</gtr:description><gtr:id>52A87E3F-9577-4186-BC4A-32809352E4C5</gtr:id><gtr:impact>Ongoing collaboration</gtr:impact><gtr:outcomeId>56f5c845b7a119.31522502-1</gtr:outcomeId><gtr:partnerContribution>Helped us to establish the technique</gtr:partnerContribution><gtr:piContribution>We have worked to establish electrophysiology analysis of iPSC-derived cortical neurons</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical School</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>AE920293-6C1E-49A1-A47F-30D04D335B9D</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-1</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gurdon Institute</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>5737FD57-98DA-49B1-A1A1-2AA4109941F3</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-5</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biosciences</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>E6BFEBB9-8104-4854-8BFD-5E166D7E9C8C</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-3</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Astra Zeneca</gtr:department><gtr:description>Enhancing autophagy flux in Parkinson's disease</gtr:description><gtr:id>F02E4107-9D25-4C51-94ED-2D668E2D7B12</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b4715baa021.98296647-1</gtr:outcomeId><gtr:partnerContribution>Astra Zeneca to provide drug-like small molecules.</gtr:partnerContribution><gtr:piContribution>OPDC test drug like molecules in cellular models of Parkinson's</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Dementias Platform UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dementias Platform UK Stem Cell Partnership</gtr:description><gtr:id>792A18D5-9D17-402D-8A41-FF6C71DFC4D8</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b45b51fb5a9.91764435-1</gtr:outcomeId><gtr:partnerContribution>Members will share expertise and stem cell lines as part of DPUK Stem Cell Network</gtr:partnerContribution><gtr:piContribution>OPDC will share expertise and stem cell lines as part of DPUK Stem Cell Network</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Manchester Medical School</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>CD4991B9-129C-4FE5-BCF3-D9EE200893F5</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-4</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Alzheimer's Research UK Oxford Drug Discovery Institute</gtr:department><gtr:description>ODDI Phenotypic drug discovery in Parkinson's</gtr:description><gtr:id>556E3AC8-8C56-45F1-B013-794F28652720</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b46693869f4.62354424-1</gtr:outcomeId><gtr:partnerContribution>Collaborative drug discovery project in Parkinson's</gtr:partnerContribution><gtr:piContribution>Collaborative drug discovery project in Parkinson's</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Stem cell generation</gtr:description><gtr:id>172E1396-46ED-49BF-8F29-466A40A49BB2</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>AdWvfuJg1WM-1</gtr:outcomeId><gtr:partnerContribution>The Stem Cell Facility provides stem cells of certain MAPT genotypes for differentiation into neurons</gtr:partnerContribution><gtr:piContribution>We work with the Oxford Stem Cell Facility at Pathology to study induced pluripotent stem cells of certain MAPT genotypes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Regenerative Medicine</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>54A89497-5E00-436C-85DD-FD311E5117EF</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-2</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Luxembourg</gtr:collaboratingOrganisation><gtr:country>Luxembourg, Grand Duchy of</gtr:country><gtr:department>Faculty of Science, Technology and Communication</gtr:department><gtr:description>Twinning: Centre PD</gtr:description><gtr:id>5F4E7418-E82D-44C7-8967-443FE6110A32</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b443267e475.80758961-1</gtr:outcomeId><gtr:partnerContribution>Centre PD will share information on clinical cohorts, stem cells and neuropathology
Centre PD worked with us on the EU Twinning grant to facilitate OPDC clinical data base move from Open Clinica to Red Cap System</gtr:partnerContribution><gtr:piContribution>OPDC will share information on clinical cohorts, stem cells and neuropathology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DPUK Cambridge</gtr:description><gtr:id>C5250D15-2311-4EB0-890D-C2578B03EAB0</gtr:id><gtr:impact>Development of a strong Dementia Stem Cell Network in DPUK</gtr:impact><gtr:outcomeId>58c95ed36e7743.93709019-1</gtr:outcomeId><gtr:partnerContribution>The ARUK Stem Cell Research Centre, Cambridge has standardised the use of the Opera Phenix and Nanostring Sprint instruments for QC in iPSC reprogramming and cproduction of cortical neurons. The Phenix is used for high-throughput imaging of pluripotency markers in patient-derived lines that are generated at the centre. The lab has established a method for routine characterisation of cortical neuron productions using the Nanostring digital gene expression platform. This will facilitate harmonisation of protocols between DPUK centres, and within the STEMBANCC consortium.

The imaging platform has been used to develop methods for production of human microglia from iPSCs, and to study cell biology in patient iPSC-derived microglia, focussing on TREM2 mutatiosn. In collaboration with Talisman Therapeutics and AstraZeneca, assays have been established to measure protein uptake in cortical neurons by live imaging.</gtr:partnerContribution><gtr:piContribution>Optimisation of high-content imaging protocols with Opera Phenix imager</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK Dementia Platform (DPUK)</gtr:description><gtr:id>1D7C22FC-B130-4F8D-8169-0F573C01AA9B</gtr:id><gtr:impact>The DPUK launched in Autumn 2014. It is directed by Dr John Gallacher at the University of Cardiff, together with an executive team of investigators drawn from seven universities (Cambridge, Edinburgh, Imperial College London (ICL), Oxford, Newcastle, University College London (UCL) and Swansea), including the UCL-based MRC Unit for Lifelong Health and Ageing. The clinical research infrastructure award links DPUK with further universities, Manchester and Bristol.</gtr:impact><gtr:outcomeId>54b7f9ab6daf86.48828432-1</gtr:outcomeId><gtr:partnerContribution>The MRC Dementias Platform UK (DPUK) is a &amp;pound;53M public-private partnership, developed and led by the Medical Research Council, to accelerate progress in, and open up, dementias research. The DPUK's aims are early detection, improved treatment and ultimately, prevention, of dementias.</gtr:partnerContribution><gtr:piContribution>Many OPDC members play a leading role in the DPUK. Richard Wade-Martins head the DPUK National Dementia Stem Cell Network, Simon Lovestone heads Informatics component and Clare MacKay leads on informatics analysis of imaging. Richard and Simon are on thr DPUK Executive Committee.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dementias Platform UK Stem Cell Partnership</gtr:description><gtr:id>650169F6-6E5F-4892-B9A5-AEB4ED5F6558</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b45b51fb5a9.91764435-2</gtr:outcomeId><gtr:partnerContribution>Members will share expertise and stem cell lines as part of DPUK Stem Cell Network</gtr:partnerContribution><gtr:piContribution>OPDC will share expertise and stem cell lines as part of DPUK Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Twitter account for OPDC</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2590DD44-3964-4E44-BEB0-26FF000A59B7</gtr:id><gtr:impact>Active twitter feed for OPDC engages with other research groups and industry. 
Promotes our research, events, news and drives for study participants as well as highlighting relevant news items. 
420 followers, average Impressions 7.8k per month</gtr:impact><gtr:outcomeId>58790454c33345.61743992</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://twitter.com/OxfordPDCentre</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>OPDC Open Day 2016</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>700B47B7-3D79-4B8B-9C68-CED2C1368021</gtr:id><gtr:impact>OPDC Open Day 2016
250 OPDC study Participants and Partners registered for event. 
Day of talks from Michele Hu, Fahd Baig, Claudio Ruffmann, Tom Barber and Richard Wade-Martins. 
Discussion of what participants would like from study.
Talks filmed and podcasts added to website</gtr:impact><gtr:outcomeId>5874d331903c21.75233812</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:url>http://www.opdc.ox.ac.uk/openday2016</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at launch of UK Dementia Platform</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>86424C08-010E-4C24-AFE4-78632109F4E9</gtr:id><gtr:impact>Oxford plays a significant role in the partnership and Oxford Neuroscience researchers lead a number of projects. This was reflected in the scientific programme of launch day. Simon Lovestone (Psychiatry) gave a talk on the NIHR-MRC Dementia Deep and Frequent Phenotyping Feasibility Study while Richard Wade-Martins (DPAG) spoke on the UK Stem Cell Network.

Coverage in the media</gtr:impact><gtr:outcomeId>54b917a8343d87.24005440</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MS Society Public Event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EBD01968-F5F4-43C2-BE25-E610DC6E9F99</gtr:id><gtr:impact>A presentation to members of the MS Society</gtr:impact><gtr:outcomeId>58c960659d2bc4.84977327</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK Network Open Morning</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>15ED74F1-41B3-4B4D-A63C-2DE8AE9E13E4</gtr:id><gtr:impact>About 150-200 people attended a morning of talks from Oxford researchers, including presentations on using stem cells in dementia research.</gtr:impact><gtr:outcomeId>56ddf81ac9c108.30351651</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cecilia (Heyne) Lee Pint of Science Public Engagement Talk, Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>506C8A46-B4FA-4069-BF03-135C65C54A4D</gtr:id><gtr:impact>Pint of Science Public Engagement Talk, Oxford, Autumn 2016 on using iPSC for modelling neurodegeneration</gtr:impact><gtr:outcomeId>58c9610f00c1b1.70240513</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>OPDC YouTube channel</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>87436501-3898-4F74-BEF7-46BDAF59C5F2</gtr:id><gtr:impact>Creation of OPDC YouTube channel to collate our podcasts etc.
32 subscribers, &amp;gt;2,860 views Feb 2016-Jan 2017. 
2016 talks &amp;gt;1,450 views, 
2016 OPDC highlights video &amp;gt;350 views, 
2015 talks &amp;gt;1,000 views</gtr:impact><gtr:outcomeId>587905ed2ba642.19947208</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.youtube.com/channel/UCGzboizARwaAUFW5FjPmmZw</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Parkinson's UK Branch Richard Wade-Martins</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8EBAAC55-4AAE-4A6E-9712-05C2840C9CBA</gtr:id><gtr:impact>Prof Richard Wade-Martins on the latest projects at the Oxford Centre for Parkinson's Disease Research</gtr:impact><gtr:outcomeId>587515c05182d4.99221332</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interviews on Parkinson's</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8FF5F147-C834-417A-B3BF-BA0682CDCD37</gtr:id><gtr:impact>Radio interview to raise awareness and Parkinson's fund raising sponsored event

Raised awareness and money</gtr:impact><gtr:outcomeId>569826e65b1605.07539074</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;The Funny Side of Parkinson's&quot;</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F3B94C71-977D-49BE-95BB-D427731979A4</gtr:id><gtr:impact>&amp;quot;The Funny Side of Parkinson's&amp;quot; on BBC1. Paul Mayhew-Archer Documentary. 
Richard Wade-Martins and Fahd Baig appeared to talk about OPDC.
Paul was named best presenter at the Grierson Awards for this documentary.</gtr:impact><gtr:outcomeId>5874f7f9d695b7.15248029</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/iplayer/episode/b072xkcz/inside-out-south-parkinsons-the-funny-side</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DPUK Stakeholders Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FAA09A14-24EB-4BC7-9CDA-100B6E7F5794</gtr:id><gtr:impact>Raised awareness of use of stem cells in dementia research</gtr:impact><gtr:outcomeId>56ddfa03c60f42.77600773</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC One Saturday Breakfast News - Funny Side of Parkinson's</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F9723B66-0FDC-4E97-B35B-F8CFAEEC75B3</gtr:id><gtr:impact>Richard Wade-Martins appeared on BBC One Saturday Breakfast News with Paul Mayhew-Archer to discuss our research using stem cell technology to grow and study dopamine neurons from skin cells.</gtr:impact><gtr:outcomeId>5874f85a126b02.01801115</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-35734888</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview in Civil Service Fast Stream blog - How Stem Cells Can Boost Our Knowledge and Understanding of the Causes of Dementia</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>11381BF4-32E4-4811-9D83-E2DB2C382928</gtr:id><gtr:impact>This is the third and final in a series of interviews carried out by a group of civil servants that have dedicated time to raising money and awareness for dementia via 'The Fund', a Fast Stream initiative. Alison Leishman, Home Office, interviewed Professor Wade-Martins about his research into dementia.
Richard discussed OPDC and the DPUK.</gtr:impact><gtr:outcomeId>587cda797336c8.92618385</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>https://faststream.blog.gov.uk/2016/05/20/the-fascinating-world-of-research/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NHS Lothian Annual Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9A8C8295-1D4E-4087-9FF0-9F72285414F4</gtr:id><gtr:impact>Clinical Research : driving efficient, innovative and effective healthcare.</gtr:impact><gtr:outcomeId>58c9601193e686.42366108</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Partnership Award (Dementias Platform UK Stem Cell Partnership)</gtr:description><gtr:end>2020-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>57285374-6E30-4AEA-9F56-ED56424FAD5D</gtr:id><gtr:outcomeId>588626c43ce8a5.39572549</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>155000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Momentum Award (Microglial interactions in Alzheimer's Disease)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F1AA5EC6-40D5-49D3-ADCC-924F89C0762F</gtr:id><gtr:outcomeId>587e45a28dc6e8.92194268</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sanofi/Genzyme: Modulating GBA activity as a Parkinson's disease therapy</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Genzyme Therapeutics Ltd</gtr:fundingOrg><gtr:id>A184B1EA-9C3A-4C2B-B8A0-F197DB74DBE8</gtr:id><gtr:outcomeId>5889c78c2cebf6.35939624</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>330000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>MJ Fox Therapeutic Pipeline Program: Enhancing autophagy flux in Parkinson's disease</gtr:description><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:id>8568EEF2-7F15-4293-BA8B-0B1C06C07A94</gtr:id><gtr:outcomeId>5889c6a1645bb2.54916321</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Momentum Award (Microglial interactions in Alzheimer's Disease-informatics)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>EAEB2683-0F1D-4A15-8960-4BEFE2C1BCF7</gtr:id><gtr:outcomeId>588629f79c1719.97126174</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Alzheimer's Research UK Oxford Drug Discovery Institute</gtr:department><gtr:description>ARUK ODDI collaboration: Phenotypic drug discovery in Parkinson's</gtr:description><gtr:end>2020-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>B3CCABCA-8DD6-452B-A542-E26A1BD1B613</gtr:id><gtr:outcomeId>588b4c9b768230.31096654</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>JPND</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>ED4DEAD2-EE7D-4D8A-9989-16D5AE064AC1</gtr:id><gtr:outcomeId>569823b6591013.10174032</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Develop target discovery assays using high throughput screens</gtr:description><gtr:id>42D24AEC-A4A0-41A1-817F-4BD43A4C22D1</gtr:id><gtr:impact>New research facilty built for our work</gtr:impact><gtr:outcomeId>56982792ce7a02.54150149</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Target discovery assays</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of methods for analysis of RNA-Seq</gtr:description><gtr:id>F0432385-D83E-420B-9786-47B6F6E69888</gtr:id><gtr:impact>Understanding of gene expression profiles in selected cell population</gtr:impact><gtr:outcomeId>569827dfdbc628.53354041</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>RNA-Seq</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have been able to establish CRISPR/Cas9 gene editing in our lab as a result of this project</gtr:description><gtr:id>055AFF1F-41AD-4945-9E94-FBE52C3040BA</gtr:id><gtr:impact>We have been able to perform gene editing in iPSC lines.</gtr:impact><gtr:outcomeId>56f5c6f30416c1.81461696</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CRISPR gene editing</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>To enable the detection of a-syn oligomers in stem cell-derived dopamine neurons</gtr:description><gtr:id>F2814EB9-8091-4D12-A2CF-11043749D115</gtr:id><gtr:impact>The detection of a-syn oligomers in stem cell-derived dopamine neurons</gtr:impact><gtr:outcomeId>58c92f226e65b1.71774930</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PLA in stem cell neurons</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The ability to generate microglia from human stem cells from dementia patients</gtr:description><gtr:id>EE1B18A5-CB13-4B10-978B-93ACE71C4A9C</gtr:id><gtr:impact>We will be able to compare the function of microglia generated from patients and from controls</gtr:impact><gtr:outcomeId>58c95c059b0260.47839763</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Microglia differentiation</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Patch-clamp techniques to measure neuronal activity of stem cell-derived neurons</gtr:description><gtr:id>C4EF693A-40E5-418C-A1E6-DA0F13C8E98E</gtr:id><gtr:impact>Analaysis of stem cell-derived neurons: dopamine neurons, cortical neurons, motor neurons and medium spiny neurons</gtr:impact><gtr:outcomeId>58c95d2d7ddce7.65513659</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>In vitro electrophysiology</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The ability to perform detailed high-throughput analysis of neurons in culture</gtr:description><gtr:id>03C0B091-A892-44DB-9FF4-649E1FADF2B0</gtr:id><gtr:impact>Shared use of best practice in high-throughput analysis using Opera Phenix imager and high-throughout plate readers</gtr:impact><gtr:outcomeId>58c95ca5d1abd9.76246486</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High content, high throughput analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of stem cell-derived neuronal culture techniques using microfluidic devices to channel axonal growth.</gtr:description><gtr:id>C28971E4-ACA6-4A6F-880C-9F6E9B2F3585</gtr:id><gtr:impact>Not yet: it is ongoing development</gtr:impact><gtr:outcomeId>58c92fc5c46df9.80731551</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Dopamine neuron microfluidics</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have optimised a live cell imaging protocol for the visualisation and measurement of mitochondrial membrane potential in differentiated neurons.</gtr:description><gtr:id>49C44533-B257-4729-8E18-9C8987D258B0</gtr:id><gtr:impact>The membrane potential-sensing dye TMRM can be used to quantify membrane potential, with increased fluorescence indicating increased membrane potential.</gtr:impact><gtr:outcomeId>54b6841230ab09.24845663</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Live cell imaging techniques in iPS-derived DA neurons in vitro</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B98B9D9C-23D8-4D96-9C16-5BC32DDB06B7</gtr:id><gtr:title>The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/941b690e6547ce5d419c56976b3b3eff"><gtr:id>941b690e6547ce5d419c56976b3b3eff</gtr:id><gtr:otherNames>Booth HDE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>5a538287784392.38675761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D46EF468-E755-4ABD-9D40-22672C7E618C</gtr:id><gtr:title>Associations between Mobility, Cognition, and Brain Structure in Healthy Older Adults.</gtr:title><gtr:parentPublicationTitle>Frontiers in aging neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8954b0127be41b620d2988a973134ac1"><gtr:id>8954b0127be41b620d2988a973134ac1</gtr:id><gtr:otherNames>Demnitz N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1663-4365</gtr:issn><gtr:outcomeId>5a539a576bc0e2.50641941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B297E2C-FD8B-4B2C-87F4-E645B44B7BC1</gtr:id><gtr:title>Commentary: Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5ab96fbcbc5018f30d61bb060f6a"><gtr:id>373e5ab96fbcbc5018f30d61bb060f6a</gtr:id><gtr:otherNames>Fernandes HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1662-453X</gtr:issn><gtr:outcomeId>5874dbc0f21523.82405194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C00F646B-5915-4B8D-8427-24FC477A3388</gtr:id><gtr:title>A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ba40f80506eceb964394fdd3999a959"><gtr:id>7ba40f80506eceb964394fdd3999a959</gtr:id><gtr:otherNames>Haenseler W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5a35e4df3c2484.99918951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AA00B0A-CE64-4A70-A6F3-FCB5692D5BA3</gtr:id><gtr:title>Excess a-synuclein compromises phagocytosis in iPSC-derived macrophages.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ba40f80506eceb964394fdd3999a959"><gtr:id>7ba40f80506eceb964394fdd3999a959</gtr:id><gtr:otherNames>Haenseler W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a538286b25a44.58547207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BCADAC5-32CC-49D4-A184-2C85F4FFA5EF</gtr:id><gtr:title>Associations between self-reported sleep quality and white matter in community-dwelling older adults: A prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Human brain mapping</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/293f78705781b00caef71866af946600"><gtr:id>293f78705781b00caef71866af946600</gtr:id><gtr:otherNames>Sexton CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1065-9471</gtr:issn><gtr:outcomeId>5a539a5741a5e1.37771462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16CD89F4-1210-4322-AD6C-7F5E719E6EEF</gtr:id><gtr:title>Hand classification of fMRI ICA noise components.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59f25c1d22f78b76c78cabc79bb9535"><gtr:id>a59f25c1d22f78b76c78cabc79bb9535</gtr:id><gtr:otherNames>Griffanti L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5aa7ba1de1db05.95381896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54E1C1D3-121B-476C-B426-D648C1E5C8B4</gtr:id><gtr:title>Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders extra</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59f25c1d22f78b76c78cabc79bb9535"><gtr:id>a59f25c1d22f78b76c78cabc79bb9535</gtr:id><gtr:otherNames>Griffanti L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-5464</gtr:issn><gtr:outcomeId>5a539a582168f0.67795760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62BCB31B-947C-4A4D-9E82-D04D3566B4DA</gtr:id><gtr:title>Classification and characterization of periventricular and deep white matter hyperintensities on MRI: A study in older adults.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59f25c1d22f78b76c78cabc79bb9535"><gtr:id>a59f25c1d22f78b76c78cabc79bb9535</gtr:id><gtr:otherNames>Griffanti L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a539a57c79ea5.01184950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07EC7129-683E-4C1A-9FA7-D5673A448130</gtr:id><gtr:title>ER Stress and Autophagic Perturbations Lead to Elevated Extracellular a-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5ab96fbcbc5018f30d61bb060f6a"><gtr:id>373e5ab96fbcbc5018f30d61bb060f6a</gtr:id><gtr:otherNames>Fernandes HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5874ba5882e129.59143374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>606A9323-97B2-40B7-9C3A-F603D33DA0D8</gtr:id><gtr:title>Cortical structural involvement and cognitive dysfunction in early Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bc314b9f21b355f41faf64dd9b90238"><gtr:id>2bc314b9f21b355f41faf64dd9b90238</gtr:id><gtr:otherNames>Klein JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>5aa7ba1db7cea8.64990406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D51994B-AC42-4832-832C-8D8B3B1FC2A2</gtr:id><gtr:title>Convergent pathways in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Cell and tissue research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e4a24a0b7dfa1cab256243389aad685"><gtr:id>7e4a24a0b7dfa1cab256243389aad685</gtr:id><gtr:otherNames>Cherubini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0302-766X</gtr:issn><gtr:outcomeId>5a5382865e5589.64480984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACFE159D-A150-44FD-A39E-8B590CA21014</gtr:id><gtr:title>MAPT Genetic Variation and Neuronal Maturity Alter Isoform Expression Affecting Axonal Transport in iPSC-Derived Dopamine Neurons.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dd8b7aba2fbe96680e9ede7ffe1d947"><gtr:id>9dd8b7aba2fbe96680e9ede7ffe1d947</gtr:id><gtr:otherNames>Beevers JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5a2fb184ada581.06090461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9240EB6-9D23-4A10-AA05-CFC2E0AE05D7</gtr:id><gtr:title>PET Tau and Amyloid-? Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d7a3dfce1ed86e41dbe1293fd3cc46"><gtr:id>28d7a3dfce1ed86e41dbe1293fd3cc46</gtr:id><gtr:otherNames>Koychev I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5a5386583d9403.67123924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1C7E8A6-76C9-4535-B7A2-4D0676068740</gtr:id><gtr:title>Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20e231f07979e8c63ebb8a0f6367105a"><gtr:id>20e231f07979e8c63ebb8a0f6367105a</gtr:id><gtr:otherNames>Topiwala A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5a54ba972a28d7.22434838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CDCA10E-877B-47F8-8965-A3E98FB0517A</gtr:id><gtr:title>Distinct resting-state functional connections associated with episodic and visuospatial memory in older adults.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbf75e16b3f0cbd4a049bf58a6adab3b"><gtr:id>dbf75e16b3f0cbd4a049bf58a6adab3b</gtr:id><gtr:otherNames>Suri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a54ba96d17575.51153472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08E95333-BE9F-455C-A7DC-389F73B18411</gtr:id><gtr:title>Uncoupling protein 2 haplotype does not affect human brain structure and function in a sample of community-dwelling older adults.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a258279af0f7edb6feb6bba132746c37"><gtr:id>a258279af0f7edb6feb6bba132746c37</gtr:id><gtr:otherNames>Heise V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a539a570512b7.09929609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52CD875A-A5C5-4265-9780-F049494DB63E</gtr:id><gtr:title>Neuroimaging in pre-motor Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34d836a5d1834ffd6cc643b97c3e151d"><gtr:id>34d836a5d1834ffd6cc643b97c3e151d</gtr:id><gtr:otherNames>Barber TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn><gtr:outcomeId>5a537eb392b224.90338330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A88DAE5C-2A62-4135-AB29-79EFF824B741</gtr:id><gtr:title>Whole-exome sequencing of 228 patients with sporadic Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa849759e432614b8d2b3fba1f1e0521"><gtr:id>fa849759e432614b8d2b3fba1f1e0521</gtr:id><gtr:otherNames>Sandor C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a537eb48f5ee8.74574124</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>948E2C08-DC3F-4F48-8476-142BBEE876F2</gtr:id><gtr:title>Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d8c67f525e999dca7e2071e158ddb8c"><gtr:id>0d8c67f525e999dca7e2071e158ddb8c</gtr:id><gtr:otherNames>Rolinski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5874ba5aade9d7.90743184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FECF87E8-766A-4309-BD2D-36EABC832818</gtr:id><gtr:title>Challenges in the reproducibility of clinical studies with resting state fMRI: An example in early Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59f25c1d22f78b76c78cabc79bb9535"><gtr:id>a59f25c1d22f78b76c78cabc79bb9535</gtr:id><gtr:otherNames>Griffanti L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5874ba58e3c966.38977259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A844B33-2B57-4298-A973-9641C689768A</gtr:id><gtr:title>Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa849759e432614b8d2b3fba1f1e0521"><gtr:id>fa849759e432614b8d2b3fba1f1e0521</gtr:id><gtr:otherNames>Sandor C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5880ae84751f97.78461992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>090D1397-D10E-4313-8CE9-220A4C5B535C</gtr:id><gtr:title>Exploring variability in basal ganglia connectivity with functional MRI in healthy aging.</gtr:title><gtr:parentPublicationTitle>Brain imaging and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59f25c1d22f78b76c78cabc79bb9535"><gtr:id>a59f25c1d22f78b76c78cabc79bb9535</gtr:id><gtr:otherNames>Griffanti L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1931-7557</gtr:issn><gtr:outcomeId>5aa7ba1d769f20.63657882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DC889B2-6D6D-4356-BF01-D09998238B30</gtr:id><gtr:title>Effect of age and the APOE gene on metabolite concentrations in the posterior cingulate cortex.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbf75e16b3f0cbd4a049bf58a6adab3b"><gtr:id>dbf75e16b3f0cbd4a049bf58a6adab3b</gtr:id><gtr:otherNames>Suri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a539a57966ce9.80389542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E26611D1-65A3-4F6A-9571-9CAA109DA113</gtr:id><gtr:title>Sub-threshold depressive symptoms and brain structure: A magnetic resonance imaging study within the Whitehall II cohort.</gtr:title><gtr:parentPublicationTitle>Journal of affective disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d0703425eafa2156307a6091dd47471"><gtr:id>3d0703425eafa2156307a6091dd47471</gtr:id><gtr:otherNames>Allan CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0165-0327</gtr:issn><gtr:outcomeId>5a54ba9762eee6.59091799</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_EX_MR/N50192X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>